Avoiding pitfalls: What an endoscopist should know in liver transplantation-part ii

Digestive Diseases and Sciences

Volumn 54, Issue 7, 2009, Pages 1386-1402

  Sharma, Sharad ^a   Gurakar, Ahmet ^a   Camci, Cemalettin ^a   Jabbour, Nicolas ^a  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

Author keywords

Candida; Clostridium difficile; CMV; Colitis; Endoscopy; Esophagitis; GVHD; Inflammatory bowel disease; Kaposi sarcoma; Liver transplant; Neoplasm; Peptic ulcer; PTLD; Reflux; Varices

Indexed keywords

ARTICLE; CANDIDA; CANDIDIASIS; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON TUMOR; CYTOMEGALOVIRUS INFECTION; ENDOSCOPY; ENTERITIS; ESOPHAGITIS; ESOPHAGUS TUMOR; ESOPHAGUS VARICES; GASTRITIS; GRAFT VERSUS HOST REACTION; HUMAN; KAPOSI SARCOMA; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MEDICAL SPECIALIST; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; REFLUX ESOPHAGITIS;

BILIARY TRACT DISEASES; CANDIDIASIS; CLOSTRIDIUM INFECTIONS; COLONIC NEOPLASMS; CYTOMEGALOVIRUS INFECTIONS; DIGESTIVE SYSTEM NEOPLASMS; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGITIS, PEPTIC; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER DISEASES; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; PEPTIC ULCER; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RECURRENCE; SARCOMA, KAPOSI;

EID: 67349135667     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0520-7     Document Type: Article

References (216)

1. http://www.optn.org/AR2007/913a-li.htm as of June 27, 2008.
2. M Navasa F Feu JC Garcia-Pagan 1993 Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis Hepatology 17 355 360 (Pubitemid 23072807)
3. Y Kita Y Harihara K Sano 2001 Reversible hepatofugal portal flow after liver transplantation using a small-for-size graft from a living donor Transpl Int 14 217 222 10.1111/j.1432-2277.2001.tb00048.x (Pubitemid 32821761)
4. R Troisi G Cammu G Militerno 2003 Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg 237 429 436 10.1097/00000658-200303000-00019
5. J Tabasco-Minguillan A Jain M Naik 1997 Gastrointestinal bleeding after liver transplantation Transplantation 63 60 67 10.1097/00007890-199701150-00012
6. M Hirata Y Kita Y Harihara 2002 Gastrointestinal bleeding after living-related liver transplantation Dig Dis Sci 47 2386 2388 10.1023/A:1020570901035
7. M Hirata Y Harihara T Kitamura 2001 The influence of donor age to graft volume increase rate in living donor liver transplantation Transplant Proc 33 1416 1417 10.1016/S0041-1345(00)02534-3
8. P Gertsch F Stipa J Ho ST Yuen I Luk IJ Lauder 1997 Changes in hepatic portal resistance and in liver morphology during regeneration: in vitro study in rats Eur J Surg 163 297 304 (Pubitemid 27215757)
9. U Settmacher NC Nussler M Glanemann 2000 Venous complications after orthotopic liver transplantation Clin Transplant 14 235 241 10.1034/j.1399-0012. 2000.140309.x
10. J Dumortier O Czyglik G Poncet 2002 Eversion thrombectomy for portal vein thrombosis during liver transplantation Am J Transplant 2 934 938 10.1034/j.1600-6143.2002.21009.x
11. F Sanchez-Bueno Q Hernandez P Ramirez 1999 Vascular complications in a series of 300 orthotopic liver transplants Transplant Proc 31 2409 2410 10.1016/S0041-1345(99)00406-6
12. J Lerut AG Tzakis K Bron 1987 Complications of venous reconstruction in human orthotopic liver transplantation Ann Surg 205 404 414 10.1097/00000658- 198704000-00011 (Pubitemid 17059433)
13. C Doria IR Marino 2003 Acute portal vein thrombosis secondary to donor/recipient portal vein diameter mismatch after orthotopic liver transplantation: a case report Int Surg 88 184 187
14. JT Wang HY Zhao YL Liu 2005 Portal vein thrombosis Hepatobiliary Pancreat Dis Int 4 515 518
15. U Ozkan L Oguzkurt F Tercan N Tokmak 2006 Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis Diagn Interv Radiol 12 105 107 (Pubitemid 43871356)
16. A Sobhonslidsuk KR Reddy 2002 Portal vein thrombosis: a concise review Am J Gastroenterol 97 535 541 10.1111/j.1572-0241.2002.05527.x (Pubitemid 34245878)
17. R Cherukuri ZJ Haskal A Naji A Shaked 1998 Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation: long-term follow-up Transplantation 65 1124 1126 10.1097/00007890-199804270-00018
18. N Hidajat H Stobbe V Griesshaber RJ Schroder R Felix 2005 Portal vein thrombosis: etiology, diagnostic strategy, therapy and management Vasa 34 81 92 10.1024/0301-1526.34.2.81
19. C Rossi A Zambruni F Ansaloni 2004 Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation Transplantation 78 938 940 10.1097/01.TP.0000137104.38602.9F
20. Adani GL, Baccarani U, Risaliti A, Sponza M, Gasparini D, Bresadola F, et al. Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. Cardiovasc Intervent Radiol. 2007;30:1222-1226. (Pubitemid 350059813)
21. Z Karasu S Hulagu A Gurakar 2001 High incidence of noninfectious esophagitis in orthotopic liver transplant (olt) recipients J Okla State Med Assoc 94 43 45
22. T Akatsu M Yoshida S Kawachi 2006 Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis Dig Dis Sci 51 2018 2022 10.1007/s10620-006-9362-3
23. S Kaur U Kaur N Agnihotri CD Tandon S Majumdar 2001 Modulation of acid secretion in common bile duct ligation-related gastropathy in wistar rats J Gastroenterol Hepatol 16 755 762 10.1046/j.1440-1746.2001.02505.x
24. T Koike S Ohara H Sekine 2001 Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion Gut 49 330 334 10.1136/gut.49.3.330
25. T Shirota M Kusano O Kawamura T Horikoshi M Mori T Sekiguchi 1999 Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings J Gastroenterol 34 553 559 10.1007/s005350050372
26. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am. 2003;17:113-134. doi: 10.1016/S0891-5520(02)00067-3
27. S Hadley AW Karchmer 1995 Fungal infections in solid organ transplant recipients Infect Dis Clin North Am 9 1045 1074 (Pubitemid 26008614)
28. PH Baehr GB McDonald 1994 Esophageal infections: risk factors, presentation, diagnosis, and treatment Gastroenterology 106 509 532 (Pubitemid 24041232)
29. DB Kaufman JR Leventhal A Koffron 2000 Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage Surgery 128 726 737 10.1067/msy.2000.108424
30. FM Verduyn Lunel JF Meis A Voss 1999 Nosocomial fungal infections: candidemia Diagn Microbiol Infect Dis 34 213 220 10.1016/S0732-8893(99)00035-8
31. G Barbaro G Barbarini G Di Lorenzo 1996 Fluconazole vs. itraconazole-flucytosine association in the treatment of esophageal candidiasis in aids patients. A double-blind, multicenter placebo-controlled study. The candida esophagitis multicenter italian study (cemis) group Chest 110 1507 1514 10.1378/chest.110.6.1507
32. DJ Diekema SA Messer AB Brueggemann 2002 Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of iowa organisms study J Clin Microbiol 40 1298 1302 10.1128/JCM.40.4.1298-1302.2002
33. CM Wilcox LN Alexander WS Clark SE Thompson 3rd 1996 Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms Gastroenterology 110 1803 1809 10.1053/gast.1996.v110. pm8964406
34. S Husain J Tollemar EA Dominguez 2003 Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study Transplantation 75 2023 2029 10.1097/01.TP.0000065178.93741.72 (Pubitemid 36793286)
35. HA Gaissert CK Breuer A Weissburg L Mermel 1999 Surgical management of necrotizing candida esophagitis Ann Thorac Surg 67 231 233 10.1016/S0003- 4975(98)01144-8
36. KL Gupta AK Ghosh R Kochhar V Jha A Chakrabarti V Sakhuja 1994 Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols Am J Gastroenterol 89 1062 1065 (Pubitemid 24201845)
37. N Singh 2000 Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy Clin Infect Dis 31 545 553 10.1086/313943
38. Karchmer AW, Samore MH, Hadley S, Collins LA, Jenkins RL, Lewis WD. Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc. 1994;106:38-47. discussion 47-38.
39. Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int. 2007;20:993-1015. (Pubitemid 350043839)
40. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis. 1995;21:1077-1089. quiz 1090-1071.
41. CN Kotton JA Fishman 2005 Viral infection in the renal transplant recipient J Am Soc Nephrol 16 1758 1774 10.1681/ASN.2004121113
42. VC Emery AV Cope EF Bowen D Gor PD Griffiths 1999 The dynamics of human cytomegalovirus replication in vivo J Exp Med 190 177 182 10.1084/jem.190.2.177
43. EA Dominguez 1995 Long-term infectious complications of liver transplantation Semin Liver Dis 15 133 138
44. A Humar D Kumar G Boivin AM Caliendo 2002 Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with cmv disease J Infect Dis 186 829 833 10.1086/342601
45. MA Schnitzler JA Lowell SP Hmiel 2003 Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of hla-dr matching J Am Soc Nephrol 14 780 785 10.1097/01.ASN.0000051599.09435.1E
46. JC Scott N Partovi MH Ensom 2004 Ganciclovir in solid organ transplant recipients: is there a role for clinical pharmacokinetic monitoring? Ther Drug Monit 26 68 77 10.1097/00007691-200402000-00014
47. E Gane F Saliba GJ Valdecasas 1997 Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The oral ganciclovir international transplantation study group Lancet 350 1729 1733 10.1016/S0140-6736(97)05535-9
48. JK McGavin KL Goa 2001 Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients Drugs 61 1153 1183 10.2165/00003495-200161080-00016 (Pubitemid 32661232)
49. DR Snydman 2005 Counterpoint: prevention of cytomegalovirus (cmv) infection and cmv disease in recipients of solid organ transplants: the case for prophylaxis Clin Infect Dis 40 709 712 10.1086/427509
50. S Sagedal A Hartmann H Rollag 2005 The impact of early cytomegalovirus infection and disease in renal transplant recipients Clin Microbiol Infect 11 518 530 10.1111/j.1469-0691.2005.01190.x
51. Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GF, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2005;CD003774.
52. MR Zamora MR Nicolls TN Hodges 2004 Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of cmv infection following lung transplantation Am J Transplant 4 1635 1642 10.1111/j.1600-6143.2004.00571.x
53. K Keven A Basu HP Tan 2004 Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning Transplant Proc 36 3107 3112 10.1016/j. transproceed.2004.11.092
54. DJ Taber E Ashcraft GM Baillie 2004 Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease Transpl Infect Dis 6 101 109 10.1111/j.1399-3062.2004.00066.x
55. EB Haagsma VE Hagens M Schaapveld 2001 Increased cancer risk after liver transplantation: a population-based study J Hepatol 34 84 91 10.1016/S0168-8278(00)00077-5
56. JI Herrero M Lorenzo J Quiroga 2005 De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival Liver Transpl 11 89 97 10.1002/lt.20319
57. FY Yao M Gautam C Palese 2006 De novo malignancies following liver transplantation: a case-control study with long-term follow-up Clin Transplant 20 617 623 10.1111/j.1399-0012.2006.00527.x
58. S Roayaie JD Schwartz MW Sung 2004 Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis Liver Transpl 10 534 540 10.1002/lt.20128
59. W Sanchez JA Talwalkar GJ Gores 2006 Will all liver transplantation patients eventually die from cancer? J Hepatol 44 13 18 10.1016/j.jhep.2005.10. 007
60. AB Jain LD Yee MA Nalesnik 1998 Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data Transplantation 66 1193 1200 10.1097/00007890-199811150-00014 (Pubitemid 28530324)
61. C Duvoux I Delacroix JP Richardet 1999 Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis Transplantation 67 418 421 10.1097/00007890-199902150-00014 (Pubitemid 29094014)
62. I Penn 1990 Cancers complicating organ transplantation N Engl J Med 323 1767 1769
63. I Penn 1994 The problem of cancer in organ transplant recipients: an overview Transplant Sci 4 23 32
64. A Diaz de Liano C Artieda C Yarnoz C Garde L Flores H Ortiz 2005 Esophageal squamous cell carcinoma after liver transplantation Clin Transl Oncol 7 518 520 10.1007/BF02717007
65. JF Trotter SR Brazer 1999 Rapid progression to high-grade dysplasia in barrett's esophagus after liver transplantation Liver Transpl Surg 5 332 333 10.1002/lt.500050405 (Pubitemid 29321252)
66. Y Ilan D Shouval E Galun 1996 Esophageal malignancy after liver transplantation in a patient with barrett's esophagus Scand J Gastroenterol 31 415 416 10.3109/00365529609006420 (Pubitemid 26119619)
67. T Hassanein A Gurakar HI Wright DH Van Thiel 1995 Major gastrointestinal bleeding occurring after liver transplantation J Okla State Med Assoc 88 114 118
68. RP Wood BWJ Shaw TE Starzl 1985 Extrahepatic complications of liver transplantation Semin Liver Dis 5 377 384
69. Y Hosotani C Kawanami K Hasegawa 2003 A role of Helicobacter pylori infection in the development of duodenal ulcer after adult living-related liver transplantation Transplantation 76 702 704 10.1097/01.TP.0000080573.91725.0E
70. HI Maaroos M Kekki T Vorobjova V Salupere P Sipponen 1994 Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. A long-term follow-up study of 25 patients Scand J Gastroenterol 29 532 536 10.3109/00365529409092468 (Pubitemid 24176442)
71. JM Guilbeau 2002 Delayed wound healing with sirolimus after liver transplant Ann Pharmacother 36 1391 1395 10.1345/aph.1A128 (Pubitemid 34925275)
72. AD Smith D Bai CE Marroquin 2005 Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus Clin Transplant 19 250 254 10.1111/j.1399-0012.2005.00332.x
73. TE Starzl CW Putnam JF Hansbrough KA Porter HA Reid 1977 Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair Surgery 81 212 221 (Pubitemid 8033887)
74. F Greif OL Bronsther DH Van Thiel 1994 The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation Ann Surg 219 40 45 10.1097/00000658-199401000-00007 (Pubitemid 24032235)
75. S Sharma A Gurakar N Jabbour 2008 Biliary strictures following liver transplantation: past, present and preventive strategies Liver Transpl 14 6 759 769 10.1002/lt.21509
76. CL Liu CM Lo SC Chan ST Fan 2004 Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage Transplantation 77 726 732 10.1097/01.TP.0000116604.89083.2F
77. R Rerknimitr S Sherman EL Fogel 2002 Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy Gastrointest Endosc 55 224 231 10.1067/mge.2002.120813
78. H Egawa Y Inomata S Uemoto 2001 Biliary anastomotic complications in 400 living related liver transplantations World J Surg 25 1300 1307 10.1007/s00268-001-0114-4
79. SA Shah DR Grant ID McGilvray 2007 Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center Am J Transplant 7 161 167 10.1111/j.1600-6143.2006.01601.x
80. S Hwang SG Lee KB Sung 2006 Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation Liver Transpl 12 831 838 10.1002/lt.20693
81. S Yazumi T Yoshimoto H Hisatsune 2006 Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis J Hepatobiliary Pancreat Surg 13 502 510 10.1007/s00534-005-1084-y
82. H Tashiro T Itamoto T Sasaki 2007 Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment World J Surg 31 2222 2229 10.1007/s00268-007-9217-x
83. WL Campbell R Sheng AB Zajko K Abu-Elmagd AJ Demetris 1994 Intrahepatic biliary strictures after liver transplantation Radiology 191 735 740 (Pubitemid 24177893)
84. JW Ostroff 2001 Post-transplant biliary problems Gastrointest Endosc Clin North Am 11 163 183 (Pubitemid 32096255)
85. C Moench A Uhrig AW Lohse G Otto 2004 CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation Liver Transpl 10 434 439 10.1002/lt.20095
86. HJ Schlitt PN Meier B Nashan 1999 Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation Ann Surg 229 137 145 10.1097/00000658-199901000-00018
87. IW Graziadei H Schwaighofer R Koch 2006 Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation Liver Transpl 12 718 725 10.1002/lt.20644
88. A Maheshwari W Maley Z Li PJ Thuluvath 2007 Biliary complications and outcomes of liver transplantation from donors after cardiac death Liver Transpl 13 1645 1653 10.1002/lt.21212
89. JJ Fung B Eghtesad K Patel-Tom 2007 Using livers from donation after cardiac death donors: a proposal to protect the true Achilles hell Liver Transpl 13 1633 1636 10.1002/lt.21388
90. C Moench K Moench AW Lohse J Thies G Otto 2003 Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion Liver Transpl 9 285 289 10.1053/jlts.2003.50015
91. DA Schwartz BT Petersen JJ Poterucha CJ Gostout 2000 Endoscopic therapy of anastomotic bile duct strictures occurring after liver transplantation Gastrointest Endosc 51 169 174 10.1016/S0016-5107(00)70413-5 (Pubitemid 30094509)
92. J Morelli HE Mulcahy IR Willner JT Cunningham P Draganov 2003 Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement Gastrointest Endosc 58 374 379 10.1067/S0016-5107(03)00011-7
93. H Wright S Sharma A Gurakar A Sebastian V Kohli N Jabbour 2008 Management of biliary stricture guided by the Spyglass Direct Visualization System in a liver transplant recipient: an innovative approach Gastrointest Endosc 67 7 1201 1203 10.1016/j.gie.2007.10.055
94. YK Chen DK Pleskow 2007 SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video) Gastrointest Endosc 65 6 832 841 10.1016/j.gie.2007.01.025
95. R Canelo NS Hakim B Ringe 2003 Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation Int Surg 88 145 151 (Pubitemid 39625496)
96. I Penn 1996 Posttransplantation de novo tumors in liver allograft recipients Liver Transpl Surg 2 52 59 10.1002/lt.500020109 (Pubitemid 26042202)
97. J Adami H Gabel B Lindelof 2003 Cancer risk following organ transplantation: a nationwide cohort study in sweden Br J Cancer 89 1221 1227 10.1038/sj.bjc.6601219
98. FE Ravat MF Spittle R Russell-Jones 2006 Primary cutaneous t-cell lymphoma occurring after organ transplantation J Am Acad Dermatol 54 668 675 10.1016/j.jaad.2005.10.015
99. R Rajakariar M Bhattacharyya A Norton 2004 Post transplant t-cell lymphoma: a case series of four patients from a single unit and review of the literature Am J Transplant 4 1534 1538 10.1111/j.1600-6143.2004.00521.x
100. MA Nalesnik L Makowka TE Starzl 1988 The diagnosis and treatment of posttransplant lymphoproliferative disorders Curr Probl Surg 25 367 472 10.1016/0011-3840(88)90011-1
101. S Caillard LY Agodoa EM Bohen KC Abbott 2006 Myeloma, hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis Transplantation 81 888 895 10.1097/01.tp.0000203554.54242.56
102. DW Hanto 1995 Classification of epstein-barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies Annu Rev Med 46 381 394 10.1146/annurev.med.46.1.381
103. DF Patton CW Wilkowski CA Hanson 1990 Epstein-barr virus-determined clonality in posttransplant lymphoproliferative disease Transplantation 49 1080 1084 10.1097/00007890-199006000-00010 (Pubitemid 20227631)
104. PS Randhawa R Jaffe AJ Demetris 1992 Expression of epstein-barr virus-encoded small rna (by the eber-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease N Engl J Med 327 1710 1714
105. L Young C Alfieri K Hennessy 1989 Expression of epstein-barr virus transformation-associated genes in tissues of patients with ebv lymphoproliferative disease N Engl J Med 321 1080 1085 (Pubitemid 19256661)
106. R Scheenstra EA Verschuuren A de Haan 2004 The value of prospective monitoring of epstein-barr virus DNA in blood samples of pediatric liver transplant recipients Transpl Infect Dis 6 15 22 10.1111/j.1399-3062.2004.00044. x
107. DL Kogan M Burroughs S Emre 1999 Prospective longitudinal analysis of quantitative epstein-barr virus polymerase chain reaction in pediatric liver transplant recipients Transplantation 67 1068 1070 10.1097/00007890-199904150- 00023
108. RJ Orentas DWJ Schauer FW Ellis J Walczak JT Casper DA Margolis 2003 Monitoring and modulation of epstein-barr virus loads in pediatric transplant patients Pediatr Transplant 7 305 314 10.1034/j.1399-3046.2003.00090.x
109. SA Riddler MC Breinig JL McKnight 1994 Increased levels of circulating epstein-barr virus (ebv)-infected lymphocytes and decreased ebv nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients Blood 84 972 984
110. DT Rowe L Qu J Reyes 1997 Use of quantitative competitive pcr to measure epstein-barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders J Clin Microbiol 35 1612 1615 (Pubitemid 27216848)
111. J Yancoski S Danielian J Ibanez 2004 Quantification of epstein-barr virus load in argentinean transplant recipients using real-time pcr J Clin Virol 31 58 65 10.1016/j.jcv.2004.02.015
112. HA Poirel A Bernheim A Schneider 2005 Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and ebv status Transplantation 80 176 184 10.1097/01.TP.0000163288.98419.0D
113. Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002;236:429-436. discussion 436-427. doi: 10.1097/00000658-200210000-00005
114. V Leblond S Choquet 2004 Lymphoproliferative disorders after liver transplantation J Hepatol 40 728 735 10.1016/j.jhep.2004.03.006
115. BP Nelson MA Nalesnik DW Bahler J Locker JJ Fung SH Swerdlow 2000 Epstein-barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 24 375 385 10.1097/00000478-200003000-00006
116. DG Koch L Christiansen J Lazarchick R Stuart IR Willner A Reuben 2007 Posttransplantation lymphoproliferative disorder - the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of epstein-barr virus Liver Transpl 13 904 912 10.1002/lt.21152
117. S Caillard V Dharnidharka L Agodoa E Bohen K Abbott 2005 Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression Transplantation 80 1233 1243 10.1097/01.tp.0000179639.98338.39
118. G Opelz C Naujokat V Daniel P Terness B Dohler 2006 Disassociation between risk of graft loss and risk of non-hodgkin lymphoma with induction agents in renal transplant recipients Transplantation 81 1227 1233 10.1097/01.tp.0000219817.18049.36
119. RC Walker WF Marshall JG Strickler 1995 Pretransplantation assessment of the risk of lymphoproliferative disorder Clin Infect Dis 20 1346 1353
120. VB Shahinian N Muirhead AM Jevnikar 2003 Epstein-barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients Transplantation 75 851 856 10.1097/01.TP.0000055098.96022.F7
121. SD Zangwill DT Hsu MR Kichuk 1998 Incidence and outcome of primary epstein-barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients J Heart Lung Transplant 17 1161 1166 (Pubitemid 29013395)
122. MA Nalesnik R Jaffe TE Starzl 1988 The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine a-prednisone immunosuppression Am J Pathol 133 173 192 (Pubitemid 18252734)
123. CE Kew 2nd R Lopez-Ben JK Smith 2000 Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation Transplantation 69 809 814 10.1097/00007890-200003150-00023 (Pubitemid 30174102)
124. BS Younes ME Ament SV McDiarmid MG Martin JH Vargas 1999 The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation J Pediatr Gastroenterol Nutr 28 380 385 10.1097/00005176-199904000-00007
125. YC Lai YH Ni ST Jou 2006 Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases Pediatr Transplant 10 390 394 10.1111/j.1399-3046.2005.00457.x
126. JS Heo JW Park KW Lee 2004 Posttransplantation lymphoproliferative disorder in pediatric liver transplantation Transplant Proc 36 2307 2308 10.1016/j.transproceed.2004.08.138
127. TE Starzl MA Nalesnik KA Porter 1984 Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy Lancet 1 583 587 10.1016/S0140-6736(84)90994-2 (Pubitemid 14156511)
128. DE Tsai CL Hardy JE Tomaszewski 2001 Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients Transplantation 71 1076 1088 10.1097/00007890-200104270-00012 (Pubitemid 32448822)
129. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991;10:877-886. discussion 886-877.
130. S Oertel RU Trappe K Zeidler 2006 Epstein-barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course Ann Hematol 85 478 484 10.1007/s00277-006-0109-1
131. J Yang Q Tao IW Flinn 2000 Characterization of epstein-barr virus-infected b cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response Blood 96 4055 4063
132. DT Rowe S Webber EM Schauer J Reyes M Green 2001 Epstein-barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease Transpl Infect Dis 3 79 87 10.1034/j.1399-3062.2001. 003002079.x
133. M Green TV Cacciarelli GV Mazariegos 1998 Serial measurement of epstein-barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease Transplantation 66 1641 1644 10.1097/00007890-199812270-00012
134. J Trofe JF Buell TM Beebe 2005 Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the israel penn international transplant tumor registry experience Am J Transplant 5 775 780 10.1111/j.1600-6143.2005.00776.x
135. IM Ghobrial TM Habermann MJ Maurer 2005 Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders J Clin Oncol 23 7574 7582 10.1200/JCO.2005.01.0934
136. SJ Stevens EA Verschuuren I Pronk 2001 Frequent monitoring of epstein-barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients Blood 97 1165 1171 10.1182/blood.V97.5.1165
137. T Matsukura A Yokoi H Egawa 2002 Significance of serial real-time pcr monitoring of ebv genome load in living donor liver transplantation Clin Transplant 16 107 112 10.1034/j.1399-0012.2002.1o112.x
138. Bodova I, Horakova J, Lukac J, Cupanikova D, Plank L. Autoimmune hemolytic anemia and chronic giant cell hepatitis. Bratisl Lek Listy (Tlacene Vyd). 2000;101:54-56.
139. I Penn 1997 Kaposi's sarcoma in transplant recipients Transplantation 64 669 673 10.1097/00007890-199709150-00001
140. G Miller MO Rigsby L Heston 1996 Antibodies to butyrate-inducible antigens of kaposi's sarcoma-associated herpesvirus in patients with hiv-1 infection N Engl J Med 334 1292 1297 10.1056/NEJM199605163342003
141. P Munoz P Alvarez F de Ory F Pozo M Rivera E Bouza 2002 Incidence and clinical characteristics of kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against hhv-8 Medicine (Baltimore) 81 293 304 10.1097/00005792-200207000-00005
142. W Qunibi O Al-Furayh K Almeshari 1998 Serologic association of human herpesvirus eight with posttransplant kaposi's sarcoma in Saudi Arabia Transplantation 65 583 585 10.1097/00007890-199802270-00024
143. S Euvrard J Kanitakis A Claudy 2003 Skin cancers after organ transplantation N Engl J Med 348 1681 1691 10.1056/NEJMra022137
144. P Aseni M Vertemati E Minola 2001 Kaposi's sarcoma in liver transplant recipients: morphological and clinical description Liver Transpl 7 816 823 10.1053/jlts.2001.26925
145. CH Lin CW Hsu YJ Chiang KF Ng CT Chiu 2002 Esophageal and gastric kaposi's sarcomas presenting as upper gastrointestinal bleeding Chang Gung Med J 25 329 333
146. JB Danzig LJ Brandt JF Reinus RS Klein 1991 Gastrointestinal malignancy in patients with aids Am J Gastroenterol 86 715 718
147. SL Friedman TL Wright DF Altman 1985 Gastrointestinal kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings Gastroenterology 89 102 108 (Pubitemid 15057919)
148. HL Ioachim V Adsay FR Giancotti B Dorsett J Melamed 1995 Kaposi's sarcoma of internal organs. A multiparameter study of 86 cases Cancer 75 1376 1385 10.1002/1097-0142(19950315)75:6<1376::AID-CNCR2820750621>3.0.CO;2-Y
149. C Frances 1998 Kaposi's sarcoma after renal transplantation Nephrol Dial Transplant 13 2768 2773 10.1093/ndt/13.11.2768
150. BJ Dezube 2002 Management of aids-related kaposi's sarcoma: advances in target discovery and treatment Expert Rev Anticancer Ther 2 193 200 10.1586/14737140.2.2.193 (Pubitemid 34679474)
151. FC Lee RT Mitsuyasu 1996 Chemotherapy of aids - related kaposi's sarcoma Hematol Oncol Clin North Am 10 1051 1068 10.1016/S0889-8588(05)70384-1 (Pubitemid 26314134)
152. C Morath M Mueller H Goldschmidt V Schwenger G Opelz M Zeier 2004 Malignancy in renal transplantation J Am Soc Nephrol 15 1582 1588 10.1097/01.ASN.0000126194.77004.9B
153. SS Kanj AI Sharara PA Clavien JD Hamilton 1996 Cytomegalovirus infection following liver transplantation: review of the literature Clin Infect Dis 22 537 549 (Pubitemid 26259186)
154. NA Wong AJ Bathgate CO Bellamy 2002 Colorectal disease in liver allograft recipients - a clinicopathological study with follow-up Eur J Gastroenterol Hepatol 14 231 236 10.1097/00042737-200203000-00005
155. N Singh C Wannstedt L Keyes 2004 Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients Transplantation 77 106 110 10.1097/01.TP.0000101289.80832.37
156. W van de Vrie RA de Man HR van Buuren WR Schouten HW Tilanus HJ Metselaar 2003 Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis Eur J Gastroenterol Hepatol 15 657 663 10.1097/00042737-200306000-00013
157. S Ardizzone G Bianchi Porro 2002 Inflammatory bowel disease: new insights into pathogenesis and treatment J Intern Med 252 475 496 10.1046/j.1365-2796. 2002.01067.x
158. TR Riley RE Schoen RG Lee J Rakela 1997 A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease Am J Gastroenterol 92 279 282 (Pubitemid 27076476)
159. AJ Czaja GL Davis J Ludwig AH Baggenstoss HF Taswell 1983 Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology Gastroenterology 85 713 717
160. I Dvorchik M Subotin AJ Demetris 2002 Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis Hepatology 35 380 384 10.1053/jhep.2002.30695
161. GV Papatheodoridis M Hamilton PK Mistry B Davidson K Rolles AK Burroughs 1998 Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis Gut 43 639 644 (Pubitemid 28520097)
162. MA Worns AW Lohse MF Neurath 2006 Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation Am J Gastroenterol 101 1931 1937 10.1111/j.1572-0241.2006.00624.x
163. G Wahbeh V Hupertz S Hallowell R Patel MR Chrisant 2003 Idiopathic colitis following cardiac transplantation: three pediatric cases Pediatr Transplant 7 464 468 10.1046/j.1399-3046.2003.00098.x
164. A Ramji DA Owen SR Erb CH Scudamore EM Yoshida 2002 Post-liver transplant crohn's disease: graft tolerance but not self-tolerance? Dig Dis Sci 47 522 527 10.1023/A:1017951632444
165. MH Holtmann MF Neurath 2003 Transplanting the genetic susceptibility to crohn's disease Gut 52 1394 1396 10.1136/gut.52.10.1394
166. M Niessner BA Volk 1995 Phenotypic and immunoregulatory analysis of intestinal t-cells in patients with inflammatory bowel disease: evaluation of an in vitro model Eur J Clin Invest 25 155 164 10.1111/j.1365-2362.1995.tb01542.x
167. M Senju F Hulstaert J Lowder DP Jewell 1991 Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and crohn's disease Gut 32 779 783 10.1136/gut.32.7.779
168. EB Haagsma AP Van Den Berg JH Kleibeuker MJ Slooff G Dijkstra 2003 Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens Aliment Pharmacol Ther 18 33 44 10.1046/j.1365-2036. 2003.01613.x
169. K Lundqvist U Broome 1997 Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study Dis Colon Rectum 40 451 456 10.1007/BF02258391
170. RC Verdonk G Dijkstra EB Haagsma 2006 Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease Am J Transplant 6 1422 1429 10.1111/j.1600-6143.2006.01333.x
171. A Moayyeri NE Daryani H Bahrami B Haghpanah A Nayyer-Habibi M Sadatsafavi 2005 Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis J Gastroenterol Hepatol 20 366 370 10.1111/j.1440-1746. 2005.03727.x
172. AS Befeler TW Lissoos TD Schiano 1998 Clinical course and management of inflammatory bowel disease after liver transplantation Transplantation 65 393 396 10.1097/00007890-199802150-00017
173. JA Fishman RH Rubin 1998 Infection in organ-transplant recipients N Engl J Med 338 1741 1751 10.1056/NEJM199806113382407
174. RS Fujinami JA Nelson L Walker MB Oldstone 1988 Sequence homology and immunologic cross-reactivity of human cytomegalovirus with hla-dr beta chain: a means for graft rejection and immunosuppression J Virol 62 100 105 (Pubitemid 18050797)
175. R Vega X Bertran M Menacho 1999 Cytomegalovirus infection in patients with inflammatory bowel disease Am J Gastroenterol 94 1053 1056 10.1111/j.1572-0241.1999.01013.x (Pubitemid 29173627)
176. Y Wada T Matsui H Matake 2003 Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment Dis Colon Rectum 46 S59 S65 10.1007/s10350-004-6497-1
177. B Crowley J Dempsey A Olujohungbe A Khan K Mutton CA Hart 2002 Unusual manifestations of primary cytomegalovirus infection in patients without hiv infection and without organ transplants J Med Virol 68 237 240 10.1002/jmv.10200
178. J Kishore U Ghoshal UC Ghoshal 2004 Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome J Med Microbiol 53 1155 1160 10.1099/jmm.0.45629-0
179. JE Lennard-Jones DM Melville BC Morson JK Ritchie CB Williams 1990 Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years Gut 31 800 806 10.1136/gut.31.7.800 (Pubitemid 20233949)
180. EVJ Loftus HI Aguilar WJ Sandborn 1998 Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation Hepatology 27 685 690 10.1002/hep.510270308
181. R Fabia MF Levy G Testa 1998 Colon carcinoma in patients undergoing liver transplantation Am J Surg 176 265 269 10.1016/S0002-9610(98)00141-X
182. A Vera BK Gunson V Ussatoff 2003 Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis Transplantation 75 1983 1988 10.1097/01.TP.0000058744.34965.38 (Pubitemid 36793279)
183. SH Itzkowitz DH Present 2005 Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease Inflamm Bowel Dis 11 314 321 10.1097/01.MIB.0000160811.76729.d5
184. JG Bartlett 1990 Clostridium difficile: clinical considerations Rev Infect Dis 12 Suppl 2 S243 S251
185. CP Kelly C Pothoulakis JT LaMont 1994 Clostridium difficile colitis N Engl J Med 330 257 262 10.1056/NEJM199401273300406
186. FF Willingham E Ticona Chavez DN Taylor 1998 Diarrhea and Clostridium difficile infection in latin American patients with aids. Working group on aids in Peru Clin Infect Dis 27 487 493 10.1086/514688
187. CA Muto M Pokrywka K Shutt 2005 A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use Infect Control Hosp Epidemiol 26 273 280 10.1086/502539
188. M Hashimoto Y Sugawara S Tamura 2007 Clostridium difficile-associated diarrhea after living donor liver transplantation World J Gastroenterol 13 2072 2076 (Pubitemid 46795844)
189. L Kyne S Sougioultzis LV McFarland CP Kelly 2002 Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea Infect Control Hosp Epidemiol 23 653 659 10.1086/501989 (Pubitemid 35315987)
190. RM Dallal BG Harbrecht AJ Boujoukas 2002 Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications Ann Surg 235 363 372 10.1097/00000658-200203000-00008
191. A Wanahita EA Goldsmith DM Musher 2002 Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile Clin Infect Dis 34 1585 1592 10.1086/340536
192. K Seppala L Hjelt P Sipponen 1981 Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study Scand J Gastroenterol 16 465 468 (Pubitemid 11078751)
193. MS Rubin LE Bodenstein KC Kent 1995 Severe Clostridium difficile colitis Dis Colon Rectum 38 350 354 10.1007/BF02054220
194. DN Gerding S Johnson LR Peterson ME Mulligan JJ Silva 1995 Clostridium difficile-associated diarrhea and colitis Infect Control Hosp Epidemiol 16 459 477
195. WL George RD Rolfe SM Finegold 1982 Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions J Clin Microbiol 15 1049 1053 (Pubitemid 12070852)
196. JG Bartlett 2002 Clinical practice. Antibiotic-associated diarrhea N Engl J Med 346 334 339 10.1056/NEJMcp011603
197. FJ Tedesco 1979 Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination Gastroenterology 77 295 297 (Pubitemid 9206041)
198. RP Bolton MA Culshaw 1986 Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile Gut 27 1169 1172 10.1136/gut.27.10.1169 (Pubitemid 16002615)
199. DG Teasley DN Gerding MM Olson 1983 Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis Lancet 2 1043 1046 10.1016/S0140-6736(83)91036-X (Pubitemid 14235361)
200. R Fekety J Silva C Kauffman B Buggy HG Deery 1989 Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens Am J Med 86 15 19 10.1016/0002-9343(89)90223-4
201. S Aslam RJ Hamill DM Musher 2005 Treatment of Clostridium difficile-associated disease: old therapies and new strategies Lancet Infect Dis 5 549 557 10.1016/S1473-3099(05)70215-2
202. S Johnson DN Gerding MM Olson 1990 Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission Am J Med 88 137 140 10.1016/0002-9343(90)90462-M
203. G Orlando A Ferrant R Schots 2005 Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up Transpl Int 18 125 129 10.1111/j.1432-2277.2004.00008.x
204. PM Ginsburg PJ Thuluvath 2005 Diarrhea in liver transplant recipients: etiology and management Liver Transpl 11 881 890 10.1002/lt.20500
205. H Kamei F Oike Y Fujimoto H Yamamoto K Tanaka T Kiuchi 2006 Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way hla matching Liver Transpl 12 140 145 10.1002/lt.20573
206. S Matthes-Martin SW Aberle C Peters 1998 Cmv-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease Bone Marrow Transplant 21 Suppl 2 S53 S56
207. R Perri M Assi J Talwalkar 2007 Graft vs. Host disease after liver transplantation: a new approach is needed Liver Transpl 13 1092 1099 10.1002/lt.21203
208. AL Taylor P Gibbs JA Bradley 2004 Acute graft versus host disease following liver transplantation: the enemy within Am J Transplant 4 466 474 10.1111/j.1600-6143.2004.00406.x
209. DM Smith E Agura G Netto 2003 Liver transplant-associated graft-versus-host disease Transplantation 75 118 126 10.1097/00007890-200301150- 00022
210. JG Whalen DM Jukic 2005 English JCr: rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation J Am Acad Dermatol 52 908 912 10.1016/j.jaad.2005.01.126
211. PF Whitington CM Rubin EM Alonso 1996 Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor Transplantation 62 1516 1519 10.1097/00007890-199611270-00025 (Pubitemid 26404680)
212. R Domiati-Saad GB Klintmalm G Netto ED Agura S Chinnakotla DM Smith 2005 Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism Am J Transplant 5 2968 2973 10.1111/j.1600-6143.2005.01110. x
213. JJ Schrager CL Vnencak-Jones SE Graber 2006 Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients Transplantation 81 21 25 10.1097/01.tp.0000190431. 94252.3f
214. JA Bombi A Nadal E Carreras 1995 Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease Am J Clin Pathol 103 690 695
215. HW Walling MD Voigt MS Stone 2004 Lichenoid graft vs. host disease following liver transplantation J Cutan Pathol 31 179 184 10.1111/j.0303-6987. 2004.00146.x
216. O Ringden M Uzunel I Rasmusson 2006 Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease Transplantation 81 1390 1397 10.1097/01.tp.0000214462.63943.14